CHENGDU SHENG NUO BIOTEC CO.,LTD. — Investor Relations & Filings
About CHENGDU SHENG NUO BIOTEC CO.,LTD.
Chengdu Sheng Nuo Biotec Co., Ltd. is a specialized biotechnology enterprise focused on the research, development, and large-scale manufacturing of peptide drugs and related products. The company provides a comprehensive range of peptide active pharmaceutical ingredients (APIs) and finished dosage forms, covering therapeutic areas such as metabolic diseases, cardiovascular health, and reproductive medicine. Key products include Liraglutide, Semaglutide, and Teriparatide. Beyond its product portfolio, the company offers integrated CDMO services, supporting global pharmaceutical partners through process development, scale-up, and clinical-to-commercial manufacturing. Utilizing advanced solid-phase and liquid-phase synthesis technologies, the firm maintains rigorous quality management systems compliant with international GMP standards to ensure high-purity peptide production for domestic and international markets.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 2025年度会计师事务所履职情况评估报告 | 2026-04-23 | Chinese | |
| 2025年可持续发展报告 | 2026-04-23 | Chinese | |
| 成都圣诺生物制药有限公司基本情况及2025年度财务报表 | 2026-04-23 | Chinese | |
| 2026年度“提质增效重回报”专项行动方案 | 2026-04-23 | Chinese | |
| 关于提请股东会授权董事会2026年度以简易程序向特定对象发行股票并办理相关事宜的公告 | 2026-04-23 | Chinese | |
| 薪酬管理制度 | 2026-04-23 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 39332213 | 2025年度会计师事务所履职情况评估报告 | 2026-04-23 | Chinese | ||
| 39332209 | 2025年可持续发展报告 | 2026-04-23 | Chinese | ||
| 39331961 | 成都圣诺生物制药有限公司基本情况及2025年度财务报表 | 2026-04-23 | Chinese | ||
| 39331921 | 2026年度“提质增效重回报”专项行动方案 | 2026-04-23 | Chinese | ||
| 39331893 | 关于提请股东会授权董事会2026年度以简易程序向特定对象发行股票并办理相关事宜的公告 | 2026-04-23 | Chinese | ||
| 39331887 | 薪酬管理制度 | 2026-04-23 | Chinese | ||
| 39331877 | 2025年度审计委员会对会计师事务所履行监督职责情况报告 | 2026-04-23 | Chinese | ||
| 39331874 | 天健会计师事务所（特殊普通合伙）关于成都圣诺生物科技股份有限公司内部控制审计报告 | 2026-04-23 | Chinese | ||
| 39331844 | 2025年年度报告 | 2026-04-23 | Chinese | ||
| 39331843 | 2025年度独立董事述职报告（徐正松、刘霞、贺泽凯、唐英凯） | 2026-04-23 | Chinese | ||
| 39331790 | 2025年度审计报告 | 2026-04-23 | Chinese | ||
| 39331632 | 2025年度董事会审计委员会履职报告 | 2026-04-23 | Chinese | ||
| 39331629 | 关于变更公司经营范围、修订《公司章程》及修订、制定部分治理制度并办理工商变更登记的公告 | 2026-04-23 | Chinese | ||
| 39331627 | 天健会计师事务所（特殊普通合伙）关于成都圣诺生物科技股份有限公司非经营性资金占用及其他关联资金往来情况的专项审计说明 | 2026-04-23 | Chinese | ||
| 39331608 | 2025年度内部控制评价报告 | 2026-04-23 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
CHENGDU SHENG NUO BIOTEC CO.,LTD. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/58161/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=58161 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=58161 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=58161 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 58161}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for CHENGDU SHENG NUO BIOTEC CO.,LTD. (id: 58161)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.